The level of antimicrobial peptides in different clinical forms of urinary tract infections in children
DOI:
https://doi.org/10.14739/2310-1237.2022.2.259894Keywords:
children, urinary tract infection, antimicrobial peptides, cathelicidin, hepcidin, lactoferrinAbstract
The aim. To study the content of antimicrobial peptides in the serum of children with urinary tract infections depending on the clinical form of the disease and to establish their pathogenetic role in the development of various clinical forms of pathology.
Materials and methods. The study groups consisted of 84 children (mean age – 10.0 ± 1.3 years). The main group was divided into subgroups: the first subgroup – 17 children with acute pyelonephritis, the second subgroup – 21 patients with chronic pyelonephritis, the third subgroup – 16 patients with acute cystitis, the fourth subgroup – 10 patients with unspecified urinary tract infections. The control group consisted of 20 relatively healthy children. The study of the content of cathelicidin, hepcidin and lactoferrin was performed by enzyme-linked immunosorbent assay.
Results. The development of urinary tract infection was accompanied by a statistically significant increase in the content of cathelicidin (P < 0.05). The highest level of serum cathelicidin was registered in children of the first (P <0.05) and third subgroups (P < 0.05). In the other two subgroups, the level of LL-37 had only a trend towards increasing (P > 0.05). The level of hepcidin in the main study group was statistically lower than in the control group (P < 0.05).
The development of chronic pyelonephritis and acute cystitis occurred amid a statistically significant decrease in hepcidin levels by 2.5 and 1.7 times (P < 0.01 and P < 0.05, respectively). The level of lactoferrin in the general group was within the control group figures (P > 0.05), however, there was a statistically significant decrease in serum lactoferrin in a subgroup of children with unspecified urinary tract infections (P < 0.05).
We determined a relationship between hepcidin and lactoferrin levels in the investigated groups and found a clear direct relationship in a subgroup of children diagnosed with chronic pyelonephritis (r = 0.58, P < 0.01).
Conclusions. Each nosological form of urinary tract infection has its own configuration of antimicrobial peptides. The analysis of the relationship between hepcidin and lactoferrin, the antimicrobial peptides that limit the access of the pathogens to serum iron, indicates the synchronization of the body’s defense mechanisms aimed at eliminating the pathogen.
References
Abaturov, A. E., Kryuchko, T. A., Lezhenko, G. A., & Zavgorodnyaya, N. Yu. (2018). Antimikrobnye peptidy i proteiny respiratornogo trakta, diagnosticheskaya znachimost' i terapevticheskie vozmozhnosti [Antimicrobial peptides and proteins of the respiratory tract, diagnostic significance and therapeutic possibilities]. Khar'kov: Planeta-Print. [in Russian].
Ahmed, A., Siman-Tov, G., Hall, G., Bhalla, N., & Narayanan, A. (2019). Human Antimicrobial Peptides as Therapeutics for Viral Infections. Viruses, 11(8), 704. https://doi.org/10.3390/v11080704
Babikir, I. H., Abugroun, E. A., Bilal, N. E., Alghasham, A. A., Abdalla, E. E., & Adam, I. (2018). The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections. BMC infectious diseases, 18(1), 17. https://doi.org/10.1186/s12879-017-2901-z
Balighian, E., & Burke, M. (2018). Urinary Tract Infections in Children. Pediatrics in review, 39(1), 3-12. https://doi.org/10.1542/pir.2017-0007
Ching, C., Schwartz, L., Spencer, J. D., & Becknell, B. (2020). Innate immunity and urinary tract infection. Pediatric nephrology, 35(7), 1183-1192. https://doi.org/10.1007/s00467-019-04269-9
Daher, R., & Karim, Z. (2017). Iron metabolism: State of the art. Transfusion clinique et biologique, 24(3), 115-119. https://doi.org/10.1016/j.tracli.2017.06.015
Daher, R., Lefebvre, T., Puy, H., & Karim, Z. (2019). Extrahepatic hepcidin production: The intriguing outcomes of recent years. World journal of clinical cases, 7(15), 1926-1936. https://doi.org/10.12998/wjcc.v7.i15.1926
't Hoen, L. A., Bogaert, G., Radmayr, C., Dogan, H. S., Nijman, R., Quaedackers, J., Rawashdeh, Y. F., Silay, M. S., Tekgul, S., Bhatt, N. R., & Stein, R. (2021). Update of the EAU/ESPU guidelines on urinary tract infections in children. Journal of pediatric urology, 17(2), 200-207. https://doi.org/10.1016/j.jpurol.2021.01.037
Jorge, P., Lourenço, A., & Pereira, M. O. (2012). New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches. Biofouling, 28(10), 1033-1061. https://doi.org/10.1080/08927014.2012.728210
Kai-Larsen, Y., Lüthje, P., Chromek, M., Peters, V., Wang, X., Holm, A., Kádas, L., Hedlund, K. O., Johansson, J., Chapman, M. R., Jacobson, S. H., Römling, U., Agerberth, B., & Brauner, A. (2010). Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS pathogens, 6(7), e1001010. https://doi.org/10.1371/journal.ppat.1001010
Kell, D. B., Heyden, E. L., & Pretorius, E. (2020). The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Frontiers in immunology, 11, 1221. https://doi.org/10.3389/fimmu.2020.01221
Krahulec, J., Hyrsová, M., Pepeliaev, S., Jílková, J., Cerný, Z., & Machálková, J. (2010). High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli. Applied microbiology and biotechnology, 88(1), 167-175. https://doi.org/10.1007/s00253-010-2736-7
Leung, K. C. A., Wong, H. C. A., Leung, A. M., & Hon, L. K. (2019). Urinary Tract Infection in Children. Recent Patents on Inflammation & Allergy Drug Discovery, 13(1), 2-18. https://doi.org/10.2174/1872213x13666181228154940
Lüthje, P., & Brauner, A. (2016). Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens, 5(1), 13. https://doi.org/10.3390/pathogens5010013
Presti, S., Manti, S., Parisi, G. F., Papale, M., Barbagallo, I. A., Li Volti, G., & Leonardi, S. (2021). Lactoferrin: Cytokine Modulation and Application in Clinical Practice. Journal of clinical medicine, 10(23), 5482. https://doi.org/10.3390/jcm10235482
Spencer, J. D., Schwaderer, A. L., Becknell, B., Watson, J., & Hains, D. S. (2014). The innate immune response during urinary tract infection and pyelonephritis. Pediatric nephrology, 29(7), 1139-1149. https://doi.org/10.1007/s00467-013-2513-9
Yan, J. H., Cai, X. Y., & Huang, Y. H. (2019). The clinical value of plasma hepcidin levels in predicting bacterial infections in febrile children. Pediatrics and neonatology, 60(4), 377-381. https://doi.org/10.1016/j.pedneo.2018.09.001
Ministry of Health of Ukraine. (2008, November 3). Pro zatverdzhennia protokolu likuvannia ditei z infektsiiamy sechovoi systemy i tubolointerstytsialnym nefrytom [About the approval of the treatment protocol for children with urinary system infections and tubulointerstitial nephritis (No. 627)]. [in Ukrainian]. https://zakon.rada.gov.ua/rada/show/v0627282-08#Text
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
